Jacobs Levy Equity Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.8M | Sell |
|
|||||
|
2025
Q2 | $16.4M | Sell |
|
|||||
|
2025
Q1 | $32.8M | Buy |
|
|||||
|
2024
Q4 | $20.9M | Sell |
|
|||||
|
2024
Q3 | $18.6M | Sell |
|
|||||
|
2024
Q2 | $22M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.3M | Sell |
|
|||||
|
2023
Q3 | $29.7M | Sell |
|
|||||
|
2023
Q2 | $44M | Sell |
|
|||||
|
2023
Q1 | $35.4M | Buy |
|
|||||
|
2022
Q4 | $26.1M | Buy |
|
|||||
|
2022
Q3 | $17.8M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $14.3M | Buy |
|
|||||
|
2021
Q4 | $12.6M | Buy |
|
|||||
|
2021
Q3 | $8.47M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $486K | Buy |
|